The care of the older adult with acute myeloid leukemia or a myelodysplastic syndrome

Larry Cripe, Cheryl K. Rutledge

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The majority of patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are 60 years of age or older. The expected survival and impact of the disease depend on its subtype. The goals of treatment are symptomatic palliation and prolongation of life. Cure is rarely achieved. The options for care range from intensive chemotherapy to transfusions to end-of-life care. Intensive therapy may prolong life modestly. However, the coexistence of co-morbid conditions and a lack of efficacy limit the number of candidates for intensive therapy. Therefore, most older individuals with MDS or AML receive supportive care with transfusions.

Original languageEnglish
Pages (from-to)35-41
Number of pages7
JournalAnnals of Long-Term Care
Volume10
Issue number10
StatePublished - Oct 1 2002

Fingerprint

Myelodysplastic Syndromes
Acute Myeloid Leukemia
Life Support Care
Terminal Care
Critical Care
Therapeutics
Drug Therapy
Survival

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

The care of the older adult with acute myeloid leukemia or a myelodysplastic syndrome. / Cripe, Larry; Rutledge, Cheryl K.

In: Annals of Long-Term Care, Vol. 10, No. 10, 01.10.2002, p. 35-41.

Research output: Contribution to journalArticle

@article{64a050677bbb4b3c88a0bb2a95c26b72,
title = "The care of the older adult with acute myeloid leukemia or a myelodysplastic syndrome",
abstract = "The majority of patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are 60 years of age or older. The expected survival and impact of the disease depend on its subtype. The goals of treatment are symptomatic palliation and prolongation of life. Cure is rarely achieved. The options for care range from intensive chemotherapy to transfusions to end-of-life care. Intensive therapy may prolong life modestly. However, the coexistence of co-morbid conditions and a lack of efficacy limit the number of candidates for intensive therapy. Therefore, most older individuals with MDS or AML receive supportive care with transfusions.",
author = "Larry Cripe and Rutledge, {Cheryl K.}",
year = "2002",
month = "10",
day = "1",
language = "English",
volume = "10",
pages = "35--41",
journal = "Annals of Long-Term Care",
issn = "1070-1370",
publisher = "HMP Communications LLP",
number = "10",

}

TY - JOUR

T1 - The care of the older adult with acute myeloid leukemia or a myelodysplastic syndrome

AU - Cripe, Larry

AU - Rutledge, Cheryl K.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - The majority of patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are 60 years of age or older. The expected survival and impact of the disease depend on its subtype. The goals of treatment are symptomatic palliation and prolongation of life. Cure is rarely achieved. The options for care range from intensive chemotherapy to transfusions to end-of-life care. Intensive therapy may prolong life modestly. However, the coexistence of co-morbid conditions and a lack of efficacy limit the number of candidates for intensive therapy. Therefore, most older individuals with MDS or AML receive supportive care with transfusions.

AB - The majority of patients diagnosed with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) are 60 years of age or older. The expected survival and impact of the disease depend on its subtype. The goals of treatment are symptomatic palliation and prolongation of life. Cure is rarely achieved. The options for care range from intensive chemotherapy to transfusions to end-of-life care. Intensive therapy may prolong life modestly. However, the coexistence of co-morbid conditions and a lack of efficacy limit the number of candidates for intensive therapy. Therefore, most older individuals with MDS or AML receive supportive care with transfusions.

UR - http://www.scopus.com/inward/record.url?scp=0036819410&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036819410&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 35

EP - 41

JO - Annals of Long-Term Care

JF - Annals of Long-Term Care

SN - 1070-1370

IS - 10

ER -